Graziano Seghezzi

Graziano Seghezzi is the Managing Partner at Sofinnova Partners, a prominent European venture capital firm specializing in Life Sciences. He joined the firm in 2006 after beginning his career in venture capital at Sofinnova in 2001. His extensive experience includes identifying and assessing investment opportunities, focusing on the creation of startups and spin-offs in the biotech sector.13

Career Highlights

• Investment Leadership: Graziano has played a pivotal role in several successful investments, including seed funding for companies like Omthera Pharmaceuticals, which went public on Nasdaq before being acquired by AstraZeneca, and GlycoVaxyn, sold to GlaxoSmithKline.14
• Board Memberships: He serves on the boards of various biotech companies, such as Mission Therapeutics, Crescendo Biologics, and Hookipa Biotech.35
• Biotech Accelerator: He co-founded BiovelocITA, Italy’s first biotech accelerator, enhancing the country’s presence in the life sciences sector.15

Educational Background

Graziano holds a degree in Genetics and Microbiology from the University of Pavia, Italy, and an MBA from RSM-Erasmus University in the Netherlands. Prior to his venture capital career, he spent five years conducting academic research at NYU School of Medicine, focusing on oncology and cardiovascular diseases.134

Vision and Impact

In his role as Managing Partner, Graziano aims to further develop Sofinnova Partners' global leadership in Life Sciences, leveraging his international expertise to drive growth strategies within the firm.26